Labeler
Eli Lilly and Company NDC Codes
Eli Lilly and Company lists 148 finished drug products in the FDA NDC Directory under NDC labeler code 0002.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Mounjaro, Zepbound, Omvoh, Foundayo, Mounjaro KwikPen, Zepbound KwikPen, Retevmo, Olumiant, ONSWIK KwikPen, Ebglyss, Taltz, Jaypirca, Trulicity, Lyumjev, LYUMJEV KwikPen
- Active ingredients
- Tirzepatide, Insulin lispro, Orforglipron calcium, Selpercatinib, Mirikizumab, Baricitinib, Insulin efsitora alfa, Lebrikizumab, Ixekizumab, Pirtobrutinib, Dulaglutide, Lasmiditan
- NDC labeler codes
- 0002
- Strengths (from the 100 most recently listed products)
- Insulin lispro 100 [iU]/mL; Tirzepatide 25 mg/mL; Tirzepatide 20.8 mg/mL; Tirzepatide 16.7 mg/mL; Tirzepatide 12.5 mg/mL; Tirzepatide 8.33 mg/mL; Tirzepatide 4.17 mg/mL; Mirikizumab 100 mg/mL; Tirzepatide 2.5 mg/.5mL; Tirzepatide 5 mg/.5mL; Tirzepatide 7.5 mg/.5mL; Tirzepatide 10 mg/.5mL; Tirzepatide 12.5 mg/.5mL; Tirzepatide 15 mg/.5mL; Lebrikizumab 250 mg/2mL; Selpercatinib 40 mg/1; Selpercatinib 80 mg/1; Baricitinib 4 mg/1; Insulin efsitora alfa 500 [iU]/mL; Insulin efsitora alfa 1000 [iU]/mL
- Dosage forms
- Injection, Solution, Tablet, Film coated, Tablet, Coated, Kit, Capsule, Tablet, Injection, Suspension
- Routes
- Subcutaneous, Oral, Intravenous
- Drug classes (FDA established)
- GLP-1 Receptor Agonist, Glucose-dependent Insulinotropic Polypeptide Receptor Agonist, Insulin Analog, Kinase Inhibitor, Interleukin-23 Antagonist, Janus Kinase Inhibitor, Interleukin-13 Antagonist, Interleukin-17A Antagonist, Estrogen Receptor Antagonist, Parathyroid Hormone Analog
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 126 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Zepboundtirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1423 | 00002-1423-0100002-1423-04 | — |
| Zepboundtirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2002 | 00002-2002-0100002-2002-04 | — |
| Taltzixekizumab | Ixekizumab 20 mg/.25mL | Injection, SolutionSubcutaneous | 0002-8900 | 00002-8900-11 | — |
| Taltzixekizumab | Ixekizumab 40 mg/.5mL | Injection, SolutionSubcutaneous | 0002-8905 | 00002-8905-11 | — |
| Zepboundtirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2457 | 00002-2457-80 | — |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2460 | 00002-2460-80 | — |
| Zepboundtirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2471 | 00002-2471-80 | — |
| Zepboundtirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2484 | 00002-2484-80 | — |
| Zepboundtirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2495 | 00002-2495-80 | — |
| Zepboundtirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2506 | 00002-2506-6100002-2506-80 | — |
| Omvohmirikizumab-mrkz | Mirikizumab 20 mg/mL | Injection, SolutionIntravenous | 0002-7575 | 00002-7575-01 | — |
| Omvohmirikizumab-mrkz | Mirikizumab 100 mg/mL | Injection, SolutionSubcutaneous | 0002-8011 | 00002-8011-2700002-8011-61 | — |
| Mounjarotirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1152 | 00002-1152-01 | — |
| Mounjarotirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1243 | 00002-1243-01 | — |
| Mounjarotirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2214 | 00002-2214-01 | — |
| Mounjarotirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2340 | 00002-2340-01 | — |
| Mounjarotirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2423 | 00002-2423-01 | — |
| Mounjarotirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | 0002-3002 | 00002-3002-01 | — |
| Jaypircapirtobrutinib | Pirtobrutinib 50 mg/1 | Tablet, CoatedOral | 0002-6902 | 00002-6902-30 | — |
| Jaypircapirtobrutinib | Pirtobrutinib 100 mg/1 | Tablet, CoatedOral | 0002-7026 | 00002-7026-6000002-7026-99 | — |
| Tauvidflortaucipir f-18 | Flortaucipir f-18 100 mCi/mL | Injection, SolutionIntravenous | 0002-1220 | 00002-1220-4800002-1220-50 | — |
| Mounjarotirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1457 | 00002-1457-80 | — |
| Mounjarotirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1460 | 00002-1460-80 | — |
| Mounjarotirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1471 | 00002-1471-80 | — |
| Mounjarotirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1484 | 00002-1484-80 | — |
| Mounjarotirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1495 | 00002-1495-80 | — |
| Mounjarotirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1506 | 00002-1506-6100002-1506-80 | — |
| Olumiantbaricitinib | Baricitinib 4 mg/1 | Tablet, Film coatedOral | 0002-4479 | 00002-4479-3000002-4479-61 | — |
| Baricitinib | Baricitinib 4 mg/1 | Tablet, Film coatedOral | 0002-6885 | 00002-6885-30 | — |
| Rezvoglar KwikPeninsulin glargine-aglr | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | 0002-8980 | 00002-8980-05 | — |
| Trulicitydulaglutide | Dulaglutide 3 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2236 | 00002-2236-80 | — |
| Trulicitydulaglutide | Dulaglutide 4.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-3182 | 00002-3182-80 | — |
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | 0002-7726 | 00002-7726-05 | — |
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0002-7728 | 00002-7728-01 | — |
| LYUMJEV KwikPeninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | 0002-8207 | 00002-8207-05 | — |
| LYUMJEV KwikPeninsulin lispro-aabc | Insulin lispro 200 [iU]/mL | Injection, SolutionSubcutaneous | 0002-8228 | 00002-8228-27 | — |
| LYUMJEV Tempo Peninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | 0002-8235 | 00002-8235-0500002-8235-99 | — |
| LYUMJEV Junior KwikPeninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | 0002-8351 | 00002-8351-05 | — |
| Retevmoselpercatinib | Selpercatinib 80 mg/1 | CapsuleOral | 0002-2980 | 00002-2980-2600002-2980-60 | — |
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | CapsuleOral | 0002-3977 | 00002-3977-60 | — |
| Insulin Lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0002-7737 | 00002-7737-01 | — |
| Insulin Lispro Junior KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | 0002-7752 | 00002-7752-05 | — |
| Insulin Lispro KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | 0002-8222 | 00002-8222-59 | — |
| Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SuspensionSubcutaneous | 0002-8233 | 00002-8233-05 | — |
| Reyvowlasmiditan | Lasmiditan 50 mg/1 | TabletOral | 0002-4312 | 00002-4312-08 | — |
| Reyvowlasmiditan | Lasmiditan 100 mg/1 | TabletOral | 0002-4491 | 00002-4491-0800002-4491-62 | — |
| Olumiantbaricitinib | Baricitinib 1 mg/1 | Tablet, Film coatedOral | 0002-4732 | 00002-4732-30 | — |
| Emgalitygalcanezumab-gnlm | Galcanezumab 100 mg/mL | Injection, SolutionSubcutaneous | 0002-3115 | 00002-3115-09 | — |
| Emgalitygalcanezumab-gnlm | Galcanezumab 120 mg/mL | Injection, SolutionSubcutaneous | 0002-1436 | 00002-1436-1100002-1436-61 | — |
| Olumiantbaricitinib | Baricitinib 2 mg/1 | Tablet, Film coatedOral | 0002-4182 | 00002-4182-3000002-4182-61 | — |
Eli Lilly and Company: common questions
- What is Eli Lilly and Company's NDC labeler code?
- 0002. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Eli Lilly and Company?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.